SEPTIN9 and colorectal carcinoma: The detection of aberrantly methylated septin 9 (SEPT9) in plasma may be a valuable and non-invasive blood-based polymerase chain reaction (PCR) test, with almost 70% sensitivity and 90% specificity for detection of CRC[13–16].